Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Winter;9(4):359-74.
doi: 10.1111/j.1527-3458.2003.tb00260.x.

Pharmacology of acamprosate: an overview

Affiliations
Review

Pharmacology of acamprosate: an overview

Teodoro Zornoza et al. CNS Drug Rev. 2003 Winter.

Abstract

In the last years important advances have been made in the development of drugs for the treatment of alcohol addiction. Acamprosate (calcium bis-acetylhomotaurine) is one of the better established drugs in this field on the European market. This review focuses first on the pharmacokinetics of acamprosate. The published data and the recent advances in our knowledge on the mechanisms involved in the intestinal absorption and elimination of this drug are summarized. The importance of pharmacokinetics for the proper clinical use of acamprosate is highlighted. The anti-relapse as well as the well-known effects of acamprosate on ethanol intake are discussed. The recent experiments in animal models of conditioned withdrawal are reviewed. These experiments, explored for the first time the anticraving effect of the drug. Finally, the proposed hypotheses on the neuropharmacological mechanism of action of acamprosate are discussed. The discussion deals with the relative importance of various hypotheses as well as with the recent experiments that support them. It is pointed out that further research is necessary in order to clearly understand the mode of action of acamprosate as well as the neurobiological mechanisms involved in alcohol dependence.

PubMed Disclaimer

References

    1. Allgaier C, Franke H, Sobottka H, Scheibler P. Acamprosate inhibits Ca2+ influx mediated by NMDA receptors and voltage‐sensitive Ca2+ channels in cultured rat mesencephalic neurones. Naunyn-Schmiedeberg's Arch Pharmacol 2000;362:440–443. - PubMed
    1. Al‐Qatari M, Bouchenafa O, Littleton J. Mechanism of action of acamprosate: Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol Clin Exp Res 1998;22:810–814. - PubMed
    1. Al‐Qatari M, Khan S, Harris B, Littleton J. Acamprosate is neuroprotective against glutamate‐induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain. Alcohol Clin Exp Res 2001;25:1276–1283. - PubMed
    1. Al‐Qatari M, Littleton J. Acamprosate inhibits the up‐regulation of calcium channels in rat brain associated with development of ethanol dependence. Alcohol Clin Exp Res 1996;20:92A.
    1. Anderberg EK, Lindmark T, Artursson P. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharmac Res 1993;10:857–864. - PubMed